JACQUELINE JONES: Open Payments
NPI 1164289872 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,032 in 71 payments from 17 companies in 2025. Trend: 2023 $70 · 2024 $64 · 2025 $2,032
Food & beverage: $2,032
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $345 |
| Corcept Therapeutics | 11 | $288 |
| Dexcom, Inc. | 9 | $201 |
| Novo Nordisk Inc | 9 | $197 |
| Mannkind Corporation | 8 | $178 |
| Insulet Corporation | 1 | $173 |
| Lilly USA, LLC | 6 | $166 |
| Ascensia Diabetes Care Us Inc. | 4 | $106 |
| Abbott Laboratories | 3 | $87 |
| Tandem Diabetes Care, Inc. | 2 | $66 |
Products named: Kerendia, Korlym, Dexcom G6 Transmitter, AFREZZA, OMNIPOD, MOUNJARO, Rybelsus, FREESTYLE LIBRE 3.
Industry payments across CA — which companies pay providers there.
